002821 凯莱英
午间休市 08-20 11:30:00
资讯
新帖
简况
异动快报：凯莱英（002821）8月20日11点23分触及涨停板
证券之星 · 37分钟前
异动快报：凯莱英（002821）8月20日11点23分触及涨停板
凯莱英盘中涨停
第一财经 · 10:06
凯莱英盘中涨停
凯莱英（002821）披露部分A股限制性股票回购注销完成公告，8月19日股价下跌3.76%
证券之星 · 08-19 22:04
凯莱英（002821）披露部分A股限制性股票回购注销完成公告，8月19日股价下跌3.76%
The Goldman Sachs Group, Inc.增持凯莱英(06821)4.41万股 每股作价约116.38港元
智通财经 · 08-19 18:58
The Goldman Sachs Group, Inc.增持凯莱英(06821)4.41万股 每股作价约116.38港元
凯莱英(06821)购回及注销11.75万股限制性A股股份
智通财经 · 08-19 17:43
凯莱英(06821)购回及注销11.75万股限制性A股股份
CXO概念有支撑 凯莱英（06821）涨2.27% 金斯瑞生物科技（01548）涨2.41%
金吾财讯 · 08-19 10:53
CXO概念有支撑 凯莱英（06821）涨2.27% 金斯瑞生物科技（01548）涨2.41%
凯莱英（002821）披露2026年A股限制性股票激励计划激励名单审核意见及公示情况的说明，8月12日股价下跌0.36%
证券之星 · 08-12
凯莱英（002821）披露2026年A股限制性股票激励计划激励名单审核意见及公示情况的说明，8月12日股价下跌0.36%
港股午评|恒生指数早盘跌0.63% CRO概念继续走高
智通财经 · 08-11
港股午评|恒生指数早盘跌0.63% CRO概念继续走高
凯莱英遭南方基金减持22.8万股 每股作价约109.61港元
新浪港股 · 08-11
凯莱英遭南方基金减持22.8万股 每股作价约109.61港元
A股收评：沪指涨1.02%，超2800股上涨！CRO概念、AI硬件板块爆发
格隆汇 · 08-07
A股收评：沪指涨1.02%，超2800股上涨！CRO概念、AI硬件板块爆发
凯莱英（002821）披露证券变动月报表，8月5日股价上涨1.1%
证券之星 · 08-05
凯莱英（002821）披露证券变动月报表，8月5日股价上涨1.1%
Norges Bank减持凯莱英(06821)9.15万股 每股作价约111.17港元
智通财经 · 08-04
Norges Bank减持凯莱英(06821)9.15万股 每股作价约111.17港元
A股创新药指数持续拉升，药明康德、凯莱英涨停
每日经济新闻 · 08-04
A股创新药指数持续拉升，药明康德、凯莱英涨停
药明康德（02359）中期业绩提振医药外包概念股 凯莱英（06821）涨7.98%
金吾财讯 · 08-04
药明康德（02359）中期业绩提振医药外包概念股 凯莱英（06821）涨7.98%
港股异动 | 凯莱英升逾8%，近日拟向上海凯莱英生物技术发展增资10.5亿元
智通财经 · 08-04
港股异动 | 凯莱英升逾8%，近日拟向上海凯莱英生物技术发展增资10.5亿元
港股开盘 | 恒指高开0.31% 医药CXO板块走强 药明康德(02359)涨近10%、中际旭创(03308)涨超9%
智通财经 · 08-04
港股开盘 | 恒指高开0.31% 医药CXO板块走强 药明康德(02359)涨近10%、中际旭创(03308)涨超9%
Schroders PLC减持凯莱英(06821)8.43万股 每股作价约108.49港元
智通财经 · 08-03
Schroders PLC减持凯莱英(06821)8.43万股 每股作价约108.49港元
凯莱英：已短时间内陆续恢复实验室和车间的生产经营
证券之星 · 07-31
凯莱英：已短时间内陆续恢复实验室和车间的生产经营
凯莱英等方向上海凯莱英生物技术发展合计增资12.4亿元人民币
美股速递 · 07-30
凯莱英等方向上海凯莱英生物技术发展合计增资12.4亿元人民币
凯莱英(06821)：建议采纳2026年H股限制性股票计划
智通财经 · 07-30
凯莱英(06821)：建议采纳2026年H股限制性股票计划
加载更多
公司概况
公司名称：
凯莱英医药集团(天津)股份有限公司
所属行业：
医药制造业
上市日期：
2016-11-18
主营业务：
凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是小分子CDMO解决方案、新兴业务。凯莱英生物AsymBio偶联药物开发平台成功入围第12届WorldADCAwards“BestADCPlatformTechnology”奖项，印证了凯莱英生物在全球抗体偶联药物CDMO领域的卓越地位。
发行价格：
30.53
{"stockData":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":187.65,"timestamp":1787198757000,"preClose":170.59,"halted":0,"volume":18214281,"delay":0,"changeRate":0.1,"floatShares":317000000,"shares":361000000,"eps":3.0775,"marketStatus":"午间休市","change":17.06,"latestTime":"08-20 11:30:00","open":180.12,"high":187.65,"low":176.03,"amount":3329000000,"amplitude":0.0681,"askPrice":0,"askSize":0,"bidPrice":187.65,"bidSize":45672,"shortable":0,"etf":0,"ttmEps":3.0775,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787202000000},"marketStatusCode":3,"adr":0,"adjPreClose":170.59,"symbolType":"stock","openAndCloseTimeList":[[1787189400000,1787196600000],[1787202000000,1787209200000]],"highLimit":187.65,"lowLimit":153.53,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":360780970,"isCdr":false,"pbRate":3.43,"roa":"--","peRate":60.974817,"roe":"1.71%","epsLYR":3.16,"committee":0,"marketValue":67679000000,"turnoverRate":0.0575,"status":0,"hkstockBrief":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":136.2,"timestamp":1787198700011,"preClose":126.5,"halted":0,"volume":1718120,"delay":0,"premium":"-37.78"},"floatMarketCap":59493000000},"requestUrl":"/m/hq/s/002821","defaultTab":"news","newsList":[{"id":"2660947041","title":"异动快报：凯莱英（002821）8月20日11点23分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2660947041","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660947041?lang=zh_cn&edition=full","pubTime":"2026-08-20 11:30","pubTimestamp":1787196642,"startTime":"0","endTime":"0","summary":"证券之星8月20日盘中消息，11点23分凯莱英（002821）触及涨停板。其所属行业医疗服务目前上涨。领涨股为和元生物。该股为创新药，减肥药，健康中国概念热股，当日创新药概念上涨6.05%，减肥药概念上涨5.93%，健康中国概念上涨4.95%。8月19日的资金流向数据方面，主力资金净流出1.4亿元，占总成交额6.68%，游资资金净流入2503.07万元，占总成交额1.2%，散户资金净流入1.15亿元，占总成交额5.49%。近5日资金流向一览见下表：凯莱英主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。相关 ETF","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000016693.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002821","LU1328615791.USD","06821","BK0239","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660477355","title":"凯莱英盘中涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2660477355","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660477355?lang=zh_cn&edition=full","pubTime":"2026-08-20 10:06","pubTimestamp":1787191615,"startTime":"0","endTime":"0","summary":"凯莱英盘中涨停","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608203847478194.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608203847478194.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1328615791.USD","002821","BK0239","BK1191","BK0132","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660566429","title":"凯莱英（002821）披露部分A股限制性股票回购注销完成公告，8月19日股价下跌3.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660566429","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660566429?lang=zh_cn&edition=full","pubTime":"2026-08-19 22:04","pubTimestamp":1787148263,"startTime":"0","endTime":"0","summary":"截至2026年8月19日收盘，凯莱英报收于170.59元，较前一交易日下跌3.76%，最新总市值为615.46亿元。公告显示，公司本次回购注销15名2025年A股限制性股票激励计划离职激励对象持有的117,500股限制性股票，其中首次授予11名离职激励对象持有106,000股，预留授予4名离职激励对象持有11,500股，占公司回购注销前总股本的0.0326%。相关股份已在中国证券登记结算有限责任公司深圳分公司完成注销手续。本次回购注销完成后，公司A+H股总股本由360,780,970股变更为360,663,470股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900042865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1328615791.USD","002821","BK0239","BK0132","03188","82846","02846","83188","BK1147","83130","03130","BK1191","399300","06821","02827","07233","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660184447","title":"The Goldman Sachs Group, Inc.增持凯莱英(06821)4.41万股 每股作价约116.38港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660184447","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660184447?lang=zh_cn&edition=full","pubTime":"2026-08-19 18:58","pubTimestamp":1787137133,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，8月14日，The Goldman Sachs Group, Inc.增持凯莱英(06821)4.41万股，每股作价116.3827港元，总金额约为513.25万港元。增持后最新持股数目约为142.01万股，最新持股比例为5.1%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482096.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2237443465.HKD","BK4588","IE0004086264.USD","LU1144417596.USD","LU1868837136.USD","BK4585","LU0096364046.USD","IE00B19Z3B42.SGD","LU1868836591.USD","LU2237443895.HKD","IE00B19Z3581.USD","LU1894683348.USD","LU2471134523.USD","LU0868494708.USD","LU0251142724.SGD","LU1894683264.USD","LU1791807156.HKD","LU2237443549.SGD","LU2471134796.USD","LU0345770308.USD","BK4552","BK4127","GSX","LU1328615791.USD","LU2265009873.SGD","LU2750360997.AUD","IE0002270589.USD","EWH","LU1868837300.USD","LU2750360641.GBP","06821","LU1668664300.SGD","IE0034235188.USD","LU0048573561.USD","BK4533","LU2471134879.HKD","LU1804176565.USD","BK0132","002821","IE00BFXG1179.USD","LU0251131958.USD","LU2237443978.SGD","IE00BSNM7G36.USD","LU0942090050.USD","LU1868836914.USD","LU0868494617.USD","LU2237443382.USD","LU0345770993.USD","LU2471134952.CNY","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660441388","title":"凯莱英(06821)购回及注销11.75万股限制性A股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2660441388","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660441388?lang=zh_cn&edition=full","pubTime":"2026-08-19 17:43","pubTimestamp":1787132621,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，截至本公告日期，已完成购回及注销11名已离职激励对象所持有的根据2025年A股计划首次授予的及四名已离职激励对象所持有的根据2025年A股计划预留授予的合计11.75万股限制性A股股份。本公司已发行股本已由3.61亿股股份(包括3.33亿股A股及2783.45万股H股)减少至3.61亿股股份(包括3.33亿股A股及2783.45万股H股)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482000.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","002821","02846","03188","02827","LU1328615791.USD","BK1191","83188","82846","06821","159982","07233","399300","BK0239","BK1147","03130","83130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660419923","title":"CXO概念有支撑 凯莱英（06821）涨2.27% 金斯瑞生物科技（01548）涨2.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660419923","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660419923?lang=zh_cn&edition=full","pubTime":"2026-08-19 10:53","pubTimestamp":1787108028,"startTime":"0","endTime":"0","summary":"金吾财讯 | CCXO概念有支撑，凯莱英 涨2.27%、金斯瑞生物科技涨2.41%、百济神州涨0.63%、方达控股涨0.79%、药明生物涨0.04%爱建证券表示，2026年初以来医药板块的持续回调与行业基本面、产业趋势发生背离，近期众多上市公司推出现金回购和增持方案，反映出对产业未来发展的充足信心，CXO、创新药及相关产业链已率先发力反弹，医药板块中长期布局良机已至。同时，该机构看好高景气CXO、器械出海、脑机接口、AI+医疗等投资机会。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1988641","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1770034418.SGD","LU0320764599.SGD","LU0043850808.USD","HK0000306685.HKD","LU0359202008.SGD","LU3063872942.SGD","BK1191","06160","02269","LU0516422366.SGD","BK1589","SG9999002463.SGD","LU0228659784.USD","CXO","LU0516422440.USD","LU0181495838.USD","LU0417516738.SGD","LU0819121731.USD","LU0828237510.HKD","LU1242518931.SGD","LU1688375341.USD","LU0052750758.USD","BK0239","BK1610","06821","01548","HK0000320223.HKD","LU0128526141.USD","LU0348825331.USD","WX","LU1720050803.USD","LU0039217434.USD","LU0708995583.HKD","LU1719994722.HKD","LU0359201612.USD","002821","LU0516423091.SGD","BK1588","LU0456827905.SGD","LU0140636845.USD","01521","BK1141","KURE","BK1576","LU0417516902.SGD","LU0572944931.SGD","LU1969619763.USD","LU2328871848.SGD","LU0588546209.SGD","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658903920","title":"凯莱英（002821）披露2026年A股限制性股票激励计划激励名单审核意见及公示情况的说明，8月12日股价下跌0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658903920","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658903920?lang=zh_cn&edition=full","pubTime":"2026-08-12 22:05","pubTimestamp":1786543517,"startTime":"0","endTime":"0","summary":"截至2026年8月12日收盘，凯莱英报收于175.0元，较前一交易日下跌0.36%，最新总市值为631.37亿元。该股当日开盘175.47元，最高179.1元，最低173.88元，成交额达19.55亿元，换手率为3.5%。公告显示，公司董事会薪酬与考核委员会对2026年A股限制性股票激励计划拟激励对象的姓名及职务进行了公示，公示时间为2026年7月9日至7月19日，通过公司内网公示，期间未收到任何异议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200039934.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","LU1328615791.USD","06821","399300","BK1191","BK0132","002821","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969219","title":"港股午评|恒生指数早盘跌0.63% CRO概念继续走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969219","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658969219?lang=zh_cn&edition=full","pubTime":"2026-08-11 12:00","pubTimestamp":1786420834,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港股恒生指数跌0.63%，跌163点，报25773点；恒生科技指数跌1.27%。港股早盘成交1158亿港元。药明康德司法取得进展，有利于CXO公司在海外争取新的订单。再鼎医药涨超5%，Q2产品收入环比增长11%，花旗看好中国业务下半年企稳。津上机床中国涨超5%，电子与AI液冷两大领域在新订单占比约四成。黄金股普遍承压。油价走高加剧通胀上行担忧，美联储鹰派释放强硬信号。中国黄金国际跌2.5%；紫金矿业跌3.5%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1251922891.USD","LU1242518857.USD","LU0049853897.USD","LU2264538146.SGD","06616","LU1242518931.SGD","LU0348814723.USD","LU0328353924.USD","LU0173614495.USD","BK1191","LU0329678337.USD","LU2097828557.USD","300408","06821","LU0165289439.USD","LU0463099449.HKD","LU0572944931.SGD","BK1109","LU0326950275.SGD","BK1169","LU1224709979.USD","LU0634319403.HKD","LU0417516738.SGD","HSI","HK0000320264.USD","LU0345780521.USD","BK1544","LU0164865239.USD","HK0000306701.USD","LU1988902786.USD","BK1583","MCHmain","07200","09088","LU1188198961.HKD","LU0345780281.USD","BK1588","LU0588546209.SGD","LU0431992006.USD","LU1105468828.SGD","LU2460026573.USD","01548","LU0106252389.USD","02099","03033","BK1594","LU0509642566.USD","LU0269904917.USD","82800","ZIJMY","LU0561508036.HKD","LU1048596156.SGD","300759","LU0828238088.HKD","09067","LU0039217434.USD","LU0348825331.USD","LU1769817179.HKD","LU0082770016.USD","07552","LU0531971595.HKD","LU0918141887.USD","09688","688062","SG9999004220.SGD","LU0106959298.USD","LU0096374516.USD","LU1282648689.USD","02899","LU0797268264.HKD","LU2039709279.SGD","JINFF","07300","HSTECH","LU0181495838.USD","IE0032431581.USD","LU2097828714.EUR","HHImain","83115","BK1170","BK1574","LU0737861772.HKD","LU2399975544.HKD","ZLAB","03037","LU2097828805.USD","LU1808992512.USD","02837","01541","BK1576","LU0348816934.USD","LU1504937902.USD","03067","07226","PONY","LU0327786744.USD","LU0287142896.SGD","02631","LU0082770016.SGD","002821","03759","LU0266512473.USD","LU0737861699.HKD","06951","SG9999001093.SGD","LU1719994722.HKD","03417","03423","LU0149721374.USD","LU2097828474.EUR","SG9999003461.SGD","LU0329678170.USD","LU0540923850.HKD","03115","LU0417516902.SGD","LU0828237510.HKD","LU0918141705.HKD","LU0266512127.USD","LU1720050803.USD","BK1161","LU0307460666.USD","LU0228659784.USD","LU0048580855.USD","LU2008162690.USD","LU0274383008.USD","03088","LU0348767384.USD","LU0828237940.HKD","LU1769817096.USD","HK0000320223.HKD","LU1794554557.SGD","LU0348766576.USD","LU0043850808.USD","LU0821914370.USD","LU0348827113.USD","601899","LU0871576103.HKD","HK0000306685.HKD","LU2226246903.HKD","BK1129","BK1592","LU0244354667.USD","03032","09115","LU0348735423.USD","BK1190","LU0140636845.USD","02833","02800","BK1587","LU0278937759.USD","03419","LU0886674414.USD","BK1183","LU0469268626.HKD","LU3063872942.SGD","LU2488822045.USD","LU2097828631.EUR","BK1141","BK1198","02026","LU1303224171.USD","LU1961090484.USD","LU0620787316.HKD","LU0370786039.SGD","LU1770034418.SGD","688234","LU0061477393.USD","SG9999002463.SGD","02493","LU2177674079.SGD","LU0164939612.USD","LU0456854461.SGD","LU1831875114.USD","LU0211977185.USD","LU1481107354.HKD","LU0164880469.USD","513600","LU1064131342.USD","LU0868486357.SGD","07500","01651","BK1505","LU0979878070.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658950072","title":"凯莱英遭南方基金减持22.8万股 每股作价约109.61港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658950072","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658950072?lang=zh_cn&edition=full","pubTime":"2026-08-11 08:00","pubTimestamp":1786406400,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端香港联交所最新数据显示，8月6日，南方基金减持凯莱英（06821）22.8万股，每股作价109.6099港元，总金额约为2499.11万港元。减持后最新持股数目为119.64万股，最新持股比例为4.30%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-08-11/doc-inimwyqt7616761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","002821","EWH","BK0132","BK1191","LU1328615791.USD","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657970076","title":"A股收评：沪指涨1.02%，超2800股上涨！CRO概念、AI硬件板块爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2657970076","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657970076?lang=zh_cn&edition=full","pubTime":"2026-08-07 15:03","pubTimestamp":1786086238,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00B0JY6N72.USD","BK0132","BK0187","LU1993786604.SGD","LU0880133367.SGD","LU1655091616.SGD","LU1807302812.USD","BK0028","BK0183","BK0188","603233","LU1226287529.USD","000001","BK0185","BK0278","002821","LU0501845795.SGD","LU1328615791.USD","LU0067412154.USD","LU0072913022.USD","06821","BK0114","LU1580142542.USD","BK0239","LU1781817850.SGD","BK0201","BK0012","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657752891","title":"凯莱英（002821）披露证券变动月报表，8月5日股价上涨1.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657752891","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657752891?lang=zh_cn&edition=full","pubTime":"2026-08-05 22:06","pubTimestamp":1785938783,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘，凯莱英报收于163.38元，较前一交易日上涨1.1%，最新总市值为589.44亿元。近日，凯莱英医药集团（天津）股份有限公司提交截至2026年7月31日的证券变动月报表。H股和A股的法定/注册股本均无变动，H股总数为27,834,510股，A股总数为332,946,460股，其中A股包含1,151,300股库存股。公司确认H股类别已符合联交所规定的公众持股量要求。现有股权激励计划项下，H股限制性股票计划下本月底可能发行或转让的股份为843,750股，其他协议无新增股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500043078.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0132","161027","002821","LU1328615791.USD","06821","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656558706","title":"Norges Bank减持凯莱英(06821)9.15万股 每股作价约111.17港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2656558706","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656558706?lang=zh_cn&edition=full","pubTime":"2026-08-04 19:20","pubTimestamp":1785842406,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，7月31日，Norges Bank减持凯莱英(06821)9.15万股，每股作价111.171港元，总金额约为1017.21万港元。减持后最新持股数目为159.26万股，持股比例为5.72%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002821","BK0132","ENOR","BK0239","06821","BK1191","EWH","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656586601","title":"A股创新药指数持续拉升，药明康德、凯莱英涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2656586601","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656586601?lang=zh_cn&edition=full","pubTime":"2026-08-04 09:39","pubTimestamp":1785807593,"startTime":"0","endTime":"0","summary":"8月4日，A股创新药指数持续拉升，药明康德涨停，百花医药、凯莱英此前涨停，博腾股份、博济医药、双成药业跟涨。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608043830740345.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608043830740345.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02359","BK1583","LU2242644610.SGD","LU1303224171.USD","BK1576","BK0216","IE00BPRC5H50.USD","LU2328871848.SGD","159858","LU0708995583.HKD","LU2495084118.USD","LU0700851271.USD","LU1997245094.SGD","LU1969619763.USD","LU0611395673.USD","LU0320764599.SGD","LU1997244956.HKD","LU0052750758.USD","LU1770034418.SGD","BK0239","603259","LU1719994722.HKD","BK0132","LU1979443071.USD","LU1997245177.USD","LU1808992512.USD","LU1251922891.USD","LU0348767384.USD","LU0456842615.SGD","LU2125910500.SGD","LU0348766576.USD","LU1328615791.USD","LU2488822045.USD","159982","BK1141","399300","IE00B543WZ88.USD","LU2045819591.USD","LU1046422090.SGD","002821","IE00B5MMRT66.SGD","LU1934453819.USD","BK1191","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656863415","title":"药明康德（02359）中期业绩提振医药外包概念股 凯莱英（06821）涨7.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656863415","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656863415?lang=zh_cn&edition=full","pubTime":"2026-08-04 09:36","pubTimestamp":1785807412,"startTime":"0","endTime":"0","summary":"金吾财讯 | 药明康德 中期业绩强劲，推动股价大涨逾14%，同步提振医药外包概念股，凯莱英涨7.98%，康龙化成涨7.58%，泰格医药涨5.62%，金斯瑞生物科技涨6.01%，药明生物涨4.95%，昭衍新药涨4.93%，维亚生物涨1.96%。据药明康德公告，上半年公司实现营业收入288.97亿元，同比增长38.93%；归属于上市公司股东的净利润110.8亿元，同比增长29.43%；扣非净利润105.72亿元，同比增长89.39%。公司计划上半年向全体股东每10股派发现金红利5.10元。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987415","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873","BK1576","LU0320764599.SGD","09939","LU1303224171.USD","159938","LU1808992512.USD","BK1610","LU0039217434.USD","HK0000306685.HKD","01548","LU2495084118.USD","LU1997245094.SGD","KURE","LU0181495838.USD","IE00BPRC5H50.USD","02269","BK1515","LU2045819591.USD","LU0856984785.SGD","LU1251922891.USD","LU0359202008.SGD","002821","LU0456842615.SGD","IE00B5MMRT66.SGD","BK1589","LU0823426308.USD","BK1583","LU0348767384.USD","SG9999002562.SGD","HK0000320223.HKD","06127","LU0979878070.USD","LU1046422090.SGD","LU0348766576.USD","BK1191","02359","03759","LU0307460666.USD","BK0239","LU0611395673.USD","LU1688375341.USD","LU2488822045.USD","603259","LU2242644610.SGD","06821","LU0516422440.USD","LU0700851271.USD","HK0000320264.USD","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656585241","title":"港股异动 | 凯莱英升逾8%，近日拟向上海凯莱英生物技术发展增资10.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2656585241","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656585241?lang=zh_cn&edition=full","pubTime":"2026-08-04 09:35","pubTimestamp":1785807328,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，凯莱英高开逾5%，截至发稿，涨5.5%，报115港元，成交额319.7万港元。消息面上，近日，凯莱英发布公告，该公司、目标公司上海凯莱英生物技术发展有限公司、凯莱英生物技术、高瓴祈睿、珠海岱恒、Hao Hong博士、凯莱同心及海河凯莱英基金订立增资协议，据此，该公司及投资者同意向目标公司股本增资，总额为人民币12.397亿元，公司、高瓴祈睿、Hao Hong博士分别出资10.5亿元、1.77亿元及1270万元。","market":"us","thumbnail":"https://static.tigerbbs.com/c5f6cd84096ca9b3b893fb788b76d134","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c5f6cd84096ca9b3b893fb788b76d134"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475561.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06821","LU1328615791.USD","BK4588","HELX","VXUS","002821","BK0132","BK1191","BK4585","WDNA","KCAI","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656816586","title":"港股开盘 | 恒指高开0.31% 医药CXO板块走强 药明康德(02359)涨近10%、中际旭创(03308)涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656816586","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656816586?lang=zh_cn&edition=full","pubTime":"2026-08-04 09:34","pubTimestamp":1785807258,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月4日，恒生指数高开0.31%，报26090.98点；恒生科技指数涨0.30%，报4890.34点。医药CXO板块大幅走强，药明康德涨近10%，药明生物涨超3%，昭衍新药涨近6%，凯莱英涨超5%，泰格医药涨近4%。药明康德此前披露半年报，上半年营收288.97亿元同比增长38.93%，并全面上调全年业绩指引。光通信板块活跃，中际旭创涨超9%。云计算及AI应用板块走高，金山云涨超5%。受隔夜美股科技板块走强带动，港股今日延续高开。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475568.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1242518857.USD","LU1242518931.SGD","WXXWY","BK1191","LU2242644610.SGD","LU0516423091.SGD","06821","LU0572944931.SGD","LU0326950275.SGD","300308","LU0417516738.SGD","HSI","LU0456827905.SGD","LU2125910500.SGD","BK1583","MCHmain","07200","09088","KURE","SG9999002562.SGD","LU2045819591.USD","LU0588546209.SGD","LU1688375341.USD","03033","82800","LU1046422090.SGD","09067","LU0039217434.USD","LU0348825331.USD","07552","LU0516423174.USD","02359","06127","02269","LU0516422366.SGD","LU0051755006.USD","BK1521","03308","BK1249","LU2039709279.SGD","LU0823426308.USD","07300","HSTECH","LU0181495838.USD","HHImain","83115","LU0823426480.USD","LU0320764599.SGD","03037","LU1880383366.USD","02837","BK1576","03067","07226","LU0327786744.USD","002821","LU0359202008.SGD","03417","03423","LU0708995583.HKD","BK1149","IE00B0JY6N72.USD","03115","LU0417516902.SGD","LU1720050803.USD","LU0307460666.USD","03088","LU0348767384.USD","BK1610","LU1794554557.SGD","LU0348766576.USD","LU0043850808.USD","03347","300347","LU0359201612.USD","03032","09115","LU0348735423.USD","BK1533","LU0140636845.USD","02800","02833","03419","LU3063872942.SGD","BK1589","BK1141","LU0819121731.USD","LU0052750758.USD","LU0856984785.SGD","BK1122","SG9999002463.SGD","603127","513600","LU0516422440.USD","LU0516422952.EUR","07500","603259","LU0456846285.SGD","LU0979878070.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656375398","title":"Schroders PLC减持凯莱英(06821)8.43万股 每股作价约108.49港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2656375398","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656375398?lang=zh_cn&edition=full","pubTime":"2026-08-03 19:10","pubTimestamp":1785755411,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，7月30日，Schroders PLC减持凯莱英(06821)8.43万股，每股作价108.488港元，总金额约914.55万港元。减持后最新持股数目为329.53万股，持股比例为11.84%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475371.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002821","06821","BK1191","EWH","BK0132","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655354868","title":"凯莱英：已短时间内陆续恢复实验室和车间的生产经营","url":"https://stock-news.laohu8.com/highlight/detail?id=2655354868","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655354868?lang=zh_cn&edition=full","pubTime":"2026-07-31 17:24","pubTimestamp":1785489870,"startTime":"0","endTime":"0","summary":"证券之星消息，凯莱英07月31日在投资者关系平台上答复投资者关心的问题。关于在手订单情况，请您关注公司于巨潮网披露的定期报告。前期敦化市遇强降雨天气，当地部门提前部署、科学应对、统筹调度排水防涝。公司在第一时间启动应急预案，全力保障人员安全、妥善安置物资，积极组织开展排水、设备检修等工作，已短时间内陆续恢复实验室和车间的生产经营。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100028942.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","002821","BK0132","06821","BK0239","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108922888","title":"凯莱英等方向上海凯莱英生物技术发展合计增资12.4亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1108922888","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108922888?lang=zh_cn&edition=full","pubTime":"2026-07-30 21:50","pubTimestamp":1785419410,"startTime":"0","endTime":"0","summary":"凯莱英（Asymchem Laboratories (Tianjin) - Co）及其关联方，将向上海凯莱英生物技术发展注入总计12.4亿元人民币的权益资本。这笔资金旨在扩充其资本实力，并推动后续业务拓展。通过此轮增资，上海凯莱英生物技术发展的股权结构有望进一步优化。此次出资行为，显示了各方对生物技术发展前景的看好，也体现了母公司战略布局的深化。具体而言，这些资金的注入，不仅有助于提升该公司在生物医药领域的研发与生产能力，更能为其在市场竞争中增添强劲动力。此次增资计划，正是凯莱英在生物科技赛道上持续加码的重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0132","LU1328615791.USD","002821","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655803998","title":"凯莱英(06821)：建议采纳2026年H股限制性股票计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2655803998","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655803998?lang=zh_cn&edition=full","pubTime":"2026-07-30 21:46","pubTimestamp":1785419215,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，于2026年7月30日，董事会决议(其中包括)建议采纳2026年H股限制性股票计划。根据上市规则第17章，2026年H股计划将构成本公司涉及发行新股份的股票计划，因此，2026年H股计划的采纳须经股东批准。本公司将适时遵守上市规则第十七章有关2026年H股计划的适用规定。本公司将召开临时股东大会就(其中包括)建议采纳2026年H股计划寻求股东批准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1474293.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0132","002821","LU1328615791.USD","06821","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787198808395,"stockEarnings":[{"period":"1week","weight":-0.0252},{"period":"1month","weight":0.0497},{"period":"3month","weight":0.3639},{"period":"6month","weight":0.7107},{"period":"1year","weight":0.6455},{"period":"ytd","weight":0.8515}],"compareEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":0.0259},{"period":"3month","weight":-0.0448},{"period":"6month","weight":-0.046},{"period":"1year","weight":0.0448},{"period":"ytd","weight":-0.0188}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"凯莱英医药集团(天津)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2016-11-18","address":"天津市滨海新区经济技术开发区洞庭三街6号","registeredCapital":"36066万元","survey":" 凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是小分子CDMO解决方案、新兴业务。凯莱英生物AsymBio偶联药物开发平台成功入围第12届WorldADCAwards“BestADCPlatformTechnology”奖项，印证了凯莱英生物在全球抗体偶联药物CDMO领域的卓越地位。","listedPrice":30.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,002821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}